Online citations, reference lists, and bibliographies.
← Back to Search

Biopharmaceutical Benchmarks 2014

G. Walsh
Published 2014 · Business, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Monoclonal antibodies continue their march on the markets, optimized so-called biobetter versions of existing biologics are also gaining ground, but the rate of biosimilar approvals has seen a dramatic slowdown in recent years.
This paper references
10.1038/nbt0706-769
Biopharmaceutical benchmarks 2006
G. Walsh (2006)
The economics of biosimilars.
E. A. Blackstone (2013)
10.1016/j.drudis.2013.11.004
Antibody-drug conjugates: current status and future directions.
Heidi L. Perez (2014)
10.1016/j.addr.2012.10.005
Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.
Kwang-Chul Kwon (2013)
10.1038/nbt0910-917
Biopharmaceutical benchmarks 2010
G. Walsh (2010)
10.1038/nbt.3003
The special case of gene therapy pricing
Troyen A. Brennan (2014)
10.1038/nbt0914-851a
Sanofi to propel inhalable insulin Afrezza into market
Jim Kling (2014)
10.1038/nature13777
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp™
Xiangguo Qiu (2014)
10.1007/s12033-010-9270-9
Single-Batch Production of Recombinant Human Polyclonal Antibodies
L. S. Nielsen (2010)
10.1182/blood.v122.21.6.6
Head-To-Head Comparison Of Obinutuzumab (GA101) Plus Chlorambucil (Clb) Versus Rituximab Plus Clb In Patients With Chronic Lymphocytic Leukemia (CLL) and Co-Existing Medical Conditions (Comorbidities): Final Stage 2 Results Of The CLL11 Trial
V. Goede (2013)
10.4161/mabs.25864
Approval of the first biosimilar antibodies in Europe
A. Beck (2013)
10.1073/pnas.1213709109
Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
G. Olinger (2012)
10.1038/78720
Biopharmaceutical benchmarks
G. Walsh (2000)
Profitability in the biosimilars market : can you translate scientific excellence into a healthy commercial return ?
D. A. Emerton (2013)
10.1089/GEN.33.4.15
Plant-Based Protein Biomanufacturing
A. Broz (2013)



This paper is referenced by
Impact de la lumière sur la production de protéines recombinantes chez Nicotiana benthamiana
Marielle Gagné (2015)
Strategies for improved Escherichia coli bioprocessing performance
Johan Jarmander (2015)
10.1038/s41598-019-45126-x
Combating viral contaminants in CHO cells by engineering innate immunity
A. T. Chiang (2019)
10.1016/j.ymeth.2017.09.008
In silico methods for design of biological therapeutics.
Ankit A Roy (2017)
10.1016/j.cels.2016.11.007
CHO Cells Can Make More Protein.
S. W. Harcum (2016)
10.1080/19420862.2015.1069454
Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics
R. Rogers (2015)
10.1007/978-1-4939-7756-7_21
AGGRESCAN3D: Toward the Prediction of the Aggregation Propensities of Protein Structures.
J. Pujols (2018)
10.1016/j.jbiosc.2016.10.011
Improved recombinant antibody production by CHO cells using a production enhancer DNA element with repeated transgene integration at a predetermined chromosomal site.
Y. Kawabe (2017)
10.1016/J.TRAC.2017.10.026
Measurement of impurities to support process development and manufacture of biopharmaceuticals
Sheun Oshinbolu (2017)
10.1016/j.tibtech.2015.03.012
Non-immunoglobulin scaffolds: a focus on their targets.
Katja Škrlec (2015)
10.1002/chem.201805297
Fluorogenic Detection and Characterization of Proteins by Aggregation-Induced Emission Methods.
S. Xie (2019)
10.1002/9783527699902.CH2
Tools Enabling Continuous and Integrated Upstream and Downstream Processes in the Manufacturing of Biologicals
R. Carvalho (2017)
10.1016/j.ab.2017.10.005
Immunoaffinity capture coupled with capillary electrophoresis - mass spectrometry to study therapeutic protein stability in vivo.
Mei Han (2017)
10.5731/pdajpst.2016.006882
Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities
F. A. Garcia (2017)
10.18725/OPARU-19531
Sweet factory: an O-glycosylation competent Escherichia coli strain for the recombinant expression of complex biopharmaceuticals
P. Mueller (2019)
High cell density perfusion process development for antibody producing Chinese Hamster Ovary cells
Y. Zhang (2017)
10.1002/biot.201700217
CRISPR-Based Targeted Epigenetic Editing Enables Gene Expression Modulation of the Silenced Beta-Galactoside Alpha-2,6-Sialyltransferase 1 in CHO Cells.
Nicolás Marx (2018)
10.1016/j.bioelechem.2018.10.001
Label-free independent quantitation of viable and non-viable cells using a multivariable multi-resonant sensor.
R. Potyrailo (2019)
10.1016/j.aca.2018.12.034
Use of MALDI-MS with solid-state hydrogen deuterium exchange for semi-automated assessment of peptide and protein physical stability in lyophilized solids.
Sneha R Kabaria (2019)
10.1016/j.ymben.2019.03.001
Metabolic engineering of Chinese hamster ovary cells towards reduced biosynthesis and accumulation of novel growth inhibitors in fed-batch cultures.
Bhanu Chandra Mulukutla (2019)
10.1007/978-1-4939-9853-1_22
Engineering Antibodies on the Surface of CHO Cells.
Annalee W Nguyen (2020)
10.1002/9781119044116.CH1
Introduction to Chemical Ligation Reactions
Lucía de la Rosa (2017)
10.1007/978-81-322-2837-0
Biomarker Discovery in the Developing World: Dissecting the Pipeline for Meeting the Challenges
Sanjeeva Srivastava (2016)
10.1371/journal.pone.0145419
Identification and Functional Characterization of Glycosylation of Recombinant Human Platelet-Derived Growth Factor-BB in Pichia pastoris
M. Dai (2015)
Apports de l'échange hydrogène/deutérium couplé à la spectrométrie de masse en protéomique structurale pour la caractérisation de complexes multi-protéiques.
Guillaume Terral (2016)
Template for Industrial Ph.D. project description
Esben M Bech (2019)
Strategies to improve Chlamydomonas reinhardtii as a recombinant protein host: from a small growth factor to a complex monoclonal antibody production
L. Cerro (2018)
10.1016/j.jbiotec.2018.08.020
Analytical assessment of clonal derivation of eukaryotic/CHO cell populations.
Christel Aebischer-Gumy (2018)
10.1002/adma.202000013
A Multistage Cooperative Nanoplatform Enables Intracellular Co-Delivery of Proteins and Chemotherapeutics for Cancer Therapy.
P. Zhang (2020)
10.1016/j.seppur.2020.117610
A two-step microengineered system for high-density cell retention from bioreactors
M. S. Syed (2021)
10.1016/j.jchromb.2018.10.019
Identification and quantification of product-related quality attributes in bio-therapeutic monoclonal antibody via a simple, and robust cation-exchange HPLC method compatible with direct online detection of UV and native ESI-QTOF-MS analysis.
Praveen Kallamvalliillam Sankaran (2018)
10.1080/21655979.2017.1377867
Green biologics: The algal chloroplast as a platform for making biopharmaceuticals
H. Taunt (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar